{"id":"W2887018003","doi":"10.1158/1538-7445.am2018-ct180","title":"Abstract CT180: Preliminary phase 1 profile of BMS-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Nivolumab; Medicine; Pharmacodynamics; Pharmacology; Pharmacokinetics; CD8; Antibody; Cancer; Internal medicine; Immune system; Immunotherapy; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001016116,0.001701361,0.001620101,0.0005357282,0.0004744165,0.001135954,0.0007529993,0.0008779027,0.003474042],"category_scores_gemma":[0.0007927846,0.0005155248,0.001097432,0.0004603601,0.0007700579,0.000968846,0.0003360033,0.003647113,0.001202723],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001361554,"about_ca_system_score_gemma":0.001996606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001662965,"about_ca_topic_score_gemma":0.005028948,"domain_scores_codex":[0.9996729,0.0001215802,0.00001571596,0.00005849051,0.00005067148,0.00008064211],"domain_scores_gemma":[0.9995096,0.00006583284,0.0000753878,0.00003292206,0.00005040085,0.0002657908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4471841,0.1260791,0.01370573,0.001224143,0.001599546,0.0008306904,0.0007185524,0.006561427,0.2205574,0.0004966006,0.01356541,0.1674773],"study_design_scores_gemma":[0.2014119,0.7491668,0.02087895,0.00005281945,0.0006533641,0.0007141679,0.0001102831,0.002284057,0.01868106,0.000258979,0.005737783,0.00004973412],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915011,0.001601503,0.0005463002,0.0003724188,0.00007827202,0.001741934,0.001777455,0.000141513,0.002239582],"genre_scores_gemma":[0.9867905,0.001446913,0.002018848,0.0007255822,0.0001581163,0.001669371,0.004502128,0.00006893553,0.002619777],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003474042,"threshold_uncertainty_score":0.01162177,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02149665341321906,"score_gpt":0.38212317834453,"score_spread":0.3606265249313109,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}